Neusoft Holds the Top Market Share of Medical Imaging Information System in China

SHENYANG, China, Sept. 19, 2023 /PRNewswire/ — Recently, IDC released the report “China’s Medical Imaging Information System Market Share in 2022″, in which Neusoft Corporation (Neusoft, SSE:600718) held the top market share in this sector due to its profound understanding of the market, continuous technological innovation, and robust service capabilities.

For years, Neusoft has been actively engaged in the medical imaging information system sector, and providing higher quality, smarter, and more accessible medical environment for doctors and patients. With PACS/RIS product capabilities as the core, Neusoft has further developed the smart medical imaging solutions. By adhering to standard examination processes within medical institutions, Neusoft aims to enhance patient satisfaction, assist doctors in accurate diagnosis, and improve hospital management, thus contributing to the overall information-based development of hospitals’ imaging business.

Neusoft’s PACS/RIS system complies with DICOM, HL7 standards and IHE specifications. It leverages the emerging technologies such as IoT, artificial intelligence and big data to provide services to various departments within medical institutions, to meet the needs of hospital administrators, doctors and patients.

Subscribe on LinkedIn

Get the free newsletter

Subscribe to MedicaEx for top news, trends & analysis

We're committed to your privacy. MedicaEx uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

PR Newswire is solely responsible for the content of the above news submissions. If there are any violations of laws, violations of the membership terms of this website, or the risk of infringing on the rights of third parties, PR Newswire will be solely responsible for legal and damage compensation. Responsibility has nothing to do with MedicaEx.

Are you in?

Subscribe to receive exclusive content and notifications to your inbox

We're committed to your privacy. MedicaEx uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.